Purinergic signaling in giant cell formation
- PMID: 22201854
- DOI: 10.2741/359
Purinergic signaling in giant cell formation
Abstract
Cell fusion into multinucleated giant cells (MGC) is an essential process that contributes to many important biological mechanisms in mammalians. In the bone and immune system, macrophages are endowed with a remarkable potential for cell fusion events as evidenced by their propensity to fuse with other cells and between themselves during both normal processes and disease. Macrophage fusion is critical for the normal development of multinucleated osteoclasts, the cells responsible for bone resorption. Macrophages from various tissue compartments also undergo fusion into MGC, a hallmark of granulomatous inflammation. To date, the mechanisms underlying macrophage fusion remain poorly understood. Receptor-ligand interactions are thought to mediate this process and several lines of evidence implicate purinergic receptors in both osteoclast and MGC formation. Notably, the P2X7 receptor for extracellular ATP is expressed in osteoclasts and in many types of granulomas associated with infection, foreign body response and sterile inflammation. Through their ability to sense extracellular cues and ATP, a messenger of intercellular communication, purinergic receptors likely contribute to cell-cell interactions that result in macrophage fusion.
Similar articles
-
Involvement of the purinergic P2X7 receptor in the formation of multinucleated giant cells.J Immunol. 2006 Nov 15;177(10):7257-65. doi: 10.4049/jimmunol.177.10.7257. J Immunol. 2006. PMID: 17082644
-
ATP downregulates P2X7 and inhibits osteoclast formation in RAW cells.Am J Physiol Cell Physiol. 2004 Aug;287(2):C403-12. doi: 10.1152/ajpcell.00361.2003. Epub 2004 Apr 7. Am J Physiol Cell Physiol. 2004. PMID: 15070812
-
P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration.FASEB J. 2011 Apr;25(4):1264-74. doi: 10.1096/fj.10-169854. Epub 2011 Jan 13. FASEB J. 2011. PMID: 21233486
-
ATP receptors and giant cell formation.J Leukoc Biol. 1999 Nov;66(5):723-6. doi: 10.1002/jlb.66.5.723. J Leukoc Biol. 1999. PMID: 10577500 Review.
-
[Human monocyte-derived multinucleated giant cells].Nihon Hansenbyo Gakkai Zasshi. 2004 Sep;73(3):245-51. doi: 10.5025/hansen.73.245. Nihon Hansenbyo Gakkai Zasshi. 2004. PMID: 15508727 Review. Japanese.
Cited by
-
Multinucleated Giant Cells: Current Insights in Phenotype, Biological Activities, and Mechanism of Formation.Front Cell Dev Biol. 2022 Apr 11;10:873226. doi: 10.3389/fcell.2022.873226. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35478968 Free PMC article. Review.
-
Establishment of c-myc-immortalized Kupffer cell line from a C57BL/6 mouse strain.Results Immunol. 2014 Aug 23;4:68-74. doi: 10.1016/j.rinim.2014.08.001. eCollection 2014. Results Immunol. 2014. PMID: 25379377 Free PMC article.
-
The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts.Sci Rep. 2017 Mar 15;7(1):196. doi: 10.1038/s41598-017-00139-2. Sci Rep. 2017. PMID: 28298636 Free PMC article.
-
Purinergic signalling in bone.Front Endocrinol (Lausanne). 2012 Sep 19;3:116. doi: 10.3389/fendo.2012.00116. eCollection 2012. Front Endocrinol (Lausanne). 2012. PMID: 23049524 Free PMC article.
-
Purinergic signaling in early inflammatory events of the foreign body response: modulating extracellular ATP as an enabling technology for engineered implants and tissues.Tissue Eng Part B Rev. 2014 Oct;20(5):392-402. doi: 10.1089/ten.TEB.2013.0554. Epub 2014 Jan 16. Tissue Eng Part B Rev. 2014. PMID: 24279914 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources